Literature DB >> 20937277

Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript.

Virginie Marcel1, Stéphane Perrier, Mustapha Aoubala, Sylvain Ageorges, Michael J Groves, Alexandra Diot, Kenneth Fernandes, Sudhir Tauro, Jean-Christophe Bourdon.   

Abstract

p53 gene expresses several protein isoforms modulating p53-mediated responses through regulation of gene expression. Here, we identify a novel p53 isoform, Δ160p53, lacking the first 159 residues. By knockdown experiments and site-directed mutagenesis, we show that Δ160p53 is encoded by Δ133p53 transcript using ATG160 as translational initiation site. This hypothesis is supported by endogenous expression of Δ160p53 in U2OS, T47D and K562 cells, the latter ones carrying a premature stop codon that impairs p53 and Δ133p53 protein expression but not the one of Δ160p53. Overall, these results show that the Δ133p53 transcript generates two different p53 isoforms, Δ133p53 and Δ160p53.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937277     DOI: 10.1016/j.febslet.2010.10.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  58 in total

1.  Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Authors:  Annemarie Koch; Jiri Hatina; Harald Rieder; Hans-Helge Seifert; Wolfgang Huckenbeck; Frank Jankowiak; Andrea R Florl; Robert Stoehr; Wolfgang A Schulz
Journal:  Cell Oncol (Dordr)       Date:  2012-06-06       Impact factor: 6.730

2.  Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α.

Authors:  Olivier Terrier; Virginie Marcel; Gaëlle Cartet; David P Lane; Bruno Lina; Manuel Rosa-Calatrava; Jean-Christophe Bourdon
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  p53 is an important regulator of CCL2 gene expression.

Authors:  X Tang; M Asano; A O'Reilly; A Farquhar; Y Yang; S Amar
Journal:  Curr Mol Med       Date:  2012-09       Impact factor: 2.222

4.  Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis.

Authors:  Marco M Candeias; Masatoshi Hagiwara; Michiyuki Matsuda
Journal:  EMBO Rep       Date:  2016-10-04       Impact factor: 8.807

5.  p53 isoform profiling in glioblastoma and injured brain.

Authors:  R Takahashi; C Giannini; J N Sarkaria; M Schroeder; J Rogers; D Mastroeni; H Scrable
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 9.867

6.  p53 suppresses CCL2-induced subcutaneous tumor xenograft.

Authors:  Xiaoren Tang; Salomon Amar
Journal:  Tumour Biol       Date:  2014-12-11

7.  Expression of p53β and Δ133p53 isoforms in different gastric tissues.

Authors:  Wansheng Ji; Na Zhang; Hongmei Zhang; Jingrong Ma; Hua Zhong; Jianxin Jiao; Zhixing Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 8.  Clinical Outcomes of TP53 Mutations in Cancers.

Authors:  Ana I Robles; Jin Jen; Curtis C Harris
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

9.  Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses.

Authors:  Jinxiong Wei; Jennifer Noto; Elena Zaika; Judith Romero-Gallo; Pelayo Correa; Wael El-Rifai; Richard M Peek; Alexander Zaika
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

Review 10.  p53 Isoforms: Key Regulators of the Cell Fate Decision.

Authors:  Sebastien M Joruiz; Jean-Christophe Bourdon
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.